Peter Luo. Adagene

WuXi-backed Ada­gene scores $69M round led by Gen­er­al At­lantic to push an­ti­bod­ies where Bris­tol-My­ers strug­gled

Back when Pe­ter Luo found­ed Ada­gene in 2012, much of Chi­na was still fo­cused on biosim­i­lars and con­tract ser­vices as the in­dus­try strug­gled to bring man­u­fac­tur­ing qual­i­ty up to glob­al stan­dards. But the Stan­ford-trained sci­en­tist and bat­tle-test­ed en­tre­pre­neur — to­geth­er with long­time friend and WuXi founder Ge Li — saw an op­por­tu­ni­ty to be­gin build­ing a plat­form play cen­tered around en­gi­neer­ing bet­ter an­ti­bod­ies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.